Background and Purpose: Information on the long-term fate of patients with chronic lower limb ischemia is limited. We investigated the long-term risk of the first ischemic and hemorrhagic cerebral stroke in patients on long-term anticoagulant therapy after reconstruction for chronic limb ischemia.
C hronic lower limb ischemia caused by atheroscle- rosis is a relatively benign disease. Only about one quarter of the patients who have intermittent claudication symptoms will deteriorate, and <5% will need amputation.1 A more serious risk for patients with chronic limb ischemia is the high prevalence of coexisting coronary and cerebrovascular disease.2-6 Some investigators have suggested that routine screening for carotid artery disease and subsequent endarterectomy of selected carotid lesions might reduce the incidence of stroke. [7] [8] [9] [10] [11] [12] There is, however, to date only limited knowledge as to the beneficial effect of carotid endarterectomy in asymptomatic lesions.13"14 In contrast, it has been demonstrated that long-term anticoagulant therapy implemented by a specialized organiza-tion may reduce the risk of cardiovascular events, including myocardial infarction and stroke. [15] [16] [17] [18] Information on the long-term risk of fatal and nonfatal stroke in patients with chronic limb ischemia is, however, limited.19~23 None of the studies have included multivariate analyses for the identification of patients who are at particular risk, and only one23 has expressed the risk of stroke as a life-table or survival curve.
Therefore, we have examined the risk of fatal and nonfatal ischemic and hemorrhagic stroke in a welldefined group of patients on long-term oral anticoagulation for chronic lower limb ischemia. In addition, we evaluated the independent effects of several clinical variables on the occurrence of these disabling and life-threatening events.
Subjects and Methods The patients included in this study and the methods of follow-up have been described in detail. 5 Briefly, between January 1958 and January 1989, 397 consecutive patients were selected for infrainguinal bypass because of severe chronic lower limb ischemia. A total of 376 patients survived the 30-day postoperative period and were included in this study. The indication for the during follow-up. Only one of these patients had highgrade stenosis of the ipsilateral carotid artery and subsequently underwent carotid endarterectomy. A second patient had a fatal ischemic stroke 8 months after his first-ever TIA.
The clinical diagnosis of ischemic or hemorrhagic cerebral stroke was confirmed by findings at either autopsy, operation, and/or CT scan in all but 6 patients (15%; Table 2 ). In 2 of these 6 patients, the clinical diagnosis of hemorrhagic stroke was supported by blood-stained cerebrospinal fluid. In the remaining four patients, the diagnosis of ischemic stroke was based on clinical symptoms only. On the basis of initial clinical assessment and further investigations, the majority of the ischemic strokes were considered as atherothrombotic strokes (21/23; 91%) and only two as cardioembolic strokes (2/23; 9%).
Ischemic strokes caused permanent neurological deficits in 5 patients (5/23; 22%) and were fatal in 12 (Fig 2A) . The occurrence was associated with the presence of several clinical variables at the time of the operation (Table 3) . Limb-threatening ischemia (Fig  2B) , prior myocardial infarction (Fig 2C) , and prior cerebrovascular events were all associated with increased risk for ischemic stroke. However, regarding primary risk factors for atherosclerosis, including systolic hypertension, smoking, and insulin-dependent diabetes mellitus, only minor differences in risks were (Fig 3A) . Their risk, however, was significantly increased in the presence of systolic hypertension (Fig 3B) or insulin-dependent diabetes mellitus (Fig 3C) . All other preoperative variables, including smoking and manifestations of atherosclerosis, did not significantly influence the occurrence of hemorrhagic stroke (Table 4) .
During long-term follow-up, 156 major vascular events occurred in 127 patients (127/376; 34%). The events observed in these patients were nonfatal cerebral stroke (19) , nonfatal myocardial infarction (28) , and cardiovascular death (109). The cumulative risk of having a first major vascular event increased steadily from 29% at 5 years to 56% at 15 years (Fig 4A) . Results of univariate analysis showed that systolic hypertension, insulin-dependent diabetes (Fig 4B) , limbthreatening ischemia, prior myocardial infarction ( Fig  4C) , and prior cerebrovascular events were all significant adverse prognostic factors for the composite outcome events (Table 5 ).
Multivariate analysis demonstrated that history of myocardial infarction was the single independent predictor associated with significant increased risk for ischemic stroke during follow-up (Table 6 ). Advanced age just failed to reach statistical significance as an independent predictor for ischemic stroke events (P=.06). Systolic hypertension and insulin-dependent diabetes were significant independent predictors for hemorrhagic stroke events (Table 6 ). Significant independent predictors for major vascular events were advanced age, insulin-dependent diabetes, and prior myocardial infarction (Table 7) . Discussion In the present study, we have found that patients who had infrainguinal bypass for chronic limb ischemia and subsequently were treated with long-term coumarin derivatives have a significant risk of cerebral stroke. In 10% of the patients, an ischemic or hemorrhagic cerebral stroke occurred during a mean follow-up period of The excellent completeness of follow-up (99%) and the confirmation of cerebral stroke by neuroimaging, operation, or autopsy in 85% of patients strongly increase the validity of our results. Our findings, however, are not easy to compare with those of other studies on the long-term risk of cerebral stroke in patients with chronic limb ischemia.20-23 The study designs differ significantly, and the reported incidences of stroke events vary from 1% to 12%. Major reasons are marked differences in duration of follow-up and lack of lifetable analysis techniques. Our results, however, cannot be extrapolated to all patients with chronic limb ischemia, because we included only patients who had reconstructive surgery for chronic limb ischemia and in addition were treated with oral anticoagulants.
The cumulative ischemic stroke risk in our patients was 12% at 15 years. This corresponds to an annual stroke rate of 0.8% and is lower than the annual stroke rate of 1.2% in a prospective study of patients with intermittent claudication treated with placebo and followed up for 1 year. 
